ORIKAN NEW ZEALAND LIMITED – Trademark Portfolio
Entity Type: 99
ORIKAN NEW ZEALAND LIMITED holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include EZICOM, EZICOM EVIEW, and EZICOM ERECEIPT. The owner is based in ALBANY, AUCKLAND.
21 WILLIAM PICKERING DRIVE
ALBANY, AUCKLAND 0632 , NZ
Showing of trademarks Trademarks
Trademark Classifications
ORIKAN NEW ZEALAND LIMITED's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does ORIKAN NEW ZEALAND LIMITED have?
ORIKAN NEW ZEALAND LIMITED has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does ORIKAN NEW ZEALAND LIMITED file in?
ORIKAN NEW ZEALAND LIMITED files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 37 (Building & Construction). Class 42 covers scientific and technological services; industrial analysis and research services.
What are ORIKAN NEW ZEALAND LIMITED's most well-known trademarks?
ORIKAN NEW ZEALAND LIMITED's registered trademark portfolio includes well-known marks such as EZICOM, EZICOM EVIEW, and EZICOM ERECEIPT. These are among 4 currently registered trademarks in the portfolio.
What is ORIKAN NEW ZEALAND LIMITED's trademark registration success rate?
ORIKAN NEW ZEALAND LIMITED has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.